Focus on social functioning in depression

R. M A Hirschfeld, M. Keller, M. Bourgeois, D. S. Baldwin, D. Healy, M. Humble, S. Kasper, S. A. Montgomery

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Depressive disorders represent a significant global health burden. By the year 2020 the contribution of psychiatric and neurological conditions to the global burden of disease is predicted to reach 15%. Despite this, depression is frequently unrecognized and undertreated; most depressed people do not seek treatment for their depression, and of those who do, most do not receive adequate treatment. Depression is a debilitating condition and the effects of the illness extend beyond the classically defined symptoms to almost every facet of an individual's life, including their social interactions; and even beyond the individual, to close relatives. The treatment of impaired social functioning has not been widely adopted as a therapeutic principle in depression, although it is recognized as an important part of the treatment of schizophrenia. However, depressed individuals experience more functional impairment than patients with other chronic medical conditions such as diabetes and hypertension. Early studies have suggested that antidepressants, in addition to improving the core symptoms of depression, are effective in the treatment of impaired social functioning; but few studies have directly compared different classes of antidepressants. This paper seeks to raise awareness of the key issues relating to the treatment of impaired social functioning in depression and to provide a basis for wider discussion of the topic prior to the establishment of treatment guidelines.

Original languageEnglish (US)
Pages (from-to)241-243
Number of pages3
JournalInternational Journal of Psychiatry in Clinical Practice
Volume2
Issue number4
StatePublished - Dec 1998

Fingerprint

Depression
Therapeutics
Antidepressive Agents
Interpersonal Relations
Depressive Disorder
Psychiatry
Schizophrenia
Guidelines
Hypertension

Keywords

  • Antidepressants
  • Depression
  • Global disease burden
  • Social functioning

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Hirschfeld, R. M. A., Keller, M., Bourgeois, M., Baldwin, D. S., Healy, D., Humble, M., ... Montgomery, S. A. (1998). Focus on social functioning in depression. International Journal of Psychiatry in Clinical Practice, 2(4), 241-243.

Focus on social functioning in depression. / Hirschfeld, R. M A; Keller, M.; Bourgeois, M.; Baldwin, D. S.; Healy, D.; Humble, M.; Kasper, S.; Montgomery, S. A.

In: International Journal of Psychiatry in Clinical Practice, Vol. 2, No. 4, 12.1998, p. 241-243.

Research output: Contribution to journalArticle

Hirschfeld, RMA, Keller, M, Bourgeois, M, Baldwin, DS, Healy, D, Humble, M, Kasper, S & Montgomery, SA 1998, 'Focus on social functioning in depression', International Journal of Psychiatry in Clinical Practice, vol. 2, no. 4, pp. 241-243.
Hirschfeld RMA, Keller M, Bourgeois M, Baldwin DS, Healy D, Humble M et al. Focus on social functioning in depression. International Journal of Psychiatry in Clinical Practice. 1998 Dec;2(4):241-243.
Hirschfeld, R. M A ; Keller, M. ; Bourgeois, M. ; Baldwin, D. S. ; Healy, D. ; Humble, M. ; Kasper, S. ; Montgomery, S. A. / Focus on social functioning in depression. In: International Journal of Psychiatry in Clinical Practice. 1998 ; Vol. 2, No. 4. pp. 241-243.
@article{8481da5ec6ec4859b8e4a51dc69ccf8b,
title = "Focus on social functioning in depression",
abstract = "Depressive disorders represent a significant global health burden. By the year 2020 the contribution of psychiatric and neurological conditions to the global burden of disease is predicted to reach 15{\%}. Despite this, depression is frequently unrecognized and undertreated; most depressed people do not seek treatment for their depression, and of those who do, most do not receive adequate treatment. Depression is a debilitating condition and the effects of the illness extend beyond the classically defined symptoms to almost every facet of an individual's life, including their social interactions; and even beyond the individual, to close relatives. The treatment of impaired social functioning has not been widely adopted as a therapeutic principle in depression, although it is recognized as an important part of the treatment of schizophrenia. However, depressed individuals experience more functional impairment than patients with other chronic medical conditions such as diabetes and hypertension. Early studies have suggested that antidepressants, in addition to improving the core symptoms of depression, are effective in the treatment of impaired social functioning; but few studies have directly compared different classes of antidepressants. This paper seeks to raise awareness of the key issues relating to the treatment of impaired social functioning in depression and to provide a basis for wider discussion of the topic prior to the establishment of treatment guidelines.",
keywords = "Antidepressants, Depression, Global disease burden, Social functioning",
author = "Hirschfeld, {R. M A} and M. Keller and M. Bourgeois and Baldwin, {D. S.} and D. Healy and M. Humble and S. Kasper and Montgomery, {S. A.}",
year = "1998",
month = "12",
language = "English (US)",
volume = "2",
pages = "241--243",
journal = "International Journal of Psychiatry in Clinical Practice",
issn = "1365-1501",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Focus on social functioning in depression

AU - Hirschfeld, R. M A

AU - Keller, M.

AU - Bourgeois, M.

AU - Baldwin, D. S.

AU - Healy, D.

AU - Humble, M.

AU - Kasper, S.

AU - Montgomery, S. A.

PY - 1998/12

Y1 - 1998/12

N2 - Depressive disorders represent a significant global health burden. By the year 2020 the contribution of psychiatric and neurological conditions to the global burden of disease is predicted to reach 15%. Despite this, depression is frequently unrecognized and undertreated; most depressed people do not seek treatment for their depression, and of those who do, most do not receive adequate treatment. Depression is a debilitating condition and the effects of the illness extend beyond the classically defined symptoms to almost every facet of an individual's life, including their social interactions; and even beyond the individual, to close relatives. The treatment of impaired social functioning has not been widely adopted as a therapeutic principle in depression, although it is recognized as an important part of the treatment of schizophrenia. However, depressed individuals experience more functional impairment than patients with other chronic medical conditions such as diabetes and hypertension. Early studies have suggested that antidepressants, in addition to improving the core symptoms of depression, are effective in the treatment of impaired social functioning; but few studies have directly compared different classes of antidepressants. This paper seeks to raise awareness of the key issues relating to the treatment of impaired social functioning in depression and to provide a basis for wider discussion of the topic prior to the establishment of treatment guidelines.

AB - Depressive disorders represent a significant global health burden. By the year 2020 the contribution of psychiatric and neurological conditions to the global burden of disease is predicted to reach 15%. Despite this, depression is frequently unrecognized and undertreated; most depressed people do not seek treatment for their depression, and of those who do, most do not receive adequate treatment. Depression is a debilitating condition and the effects of the illness extend beyond the classically defined symptoms to almost every facet of an individual's life, including their social interactions; and even beyond the individual, to close relatives. The treatment of impaired social functioning has not been widely adopted as a therapeutic principle in depression, although it is recognized as an important part of the treatment of schizophrenia. However, depressed individuals experience more functional impairment than patients with other chronic medical conditions such as diabetes and hypertension. Early studies have suggested that antidepressants, in addition to improving the core symptoms of depression, are effective in the treatment of impaired social functioning; but few studies have directly compared different classes of antidepressants. This paper seeks to raise awareness of the key issues relating to the treatment of impaired social functioning in depression and to provide a basis for wider discussion of the topic prior to the establishment of treatment guidelines.

KW - Antidepressants

KW - Depression

KW - Global disease burden

KW - Social functioning

UR - http://www.scopus.com/inward/record.url?scp=0032409767&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032409767&partnerID=8YFLogxK

M3 - Article

VL - 2

SP - 241

EP - 243

JO - International Journal of Psychiatry in Clinical Practice

JF - International Journal of Psychiatry in Clinical Practice

SN - 1365-1501

IS - 4

ER -